<DOC>
	<DOCNO>NCT00033215</DOCNO>
	<brief_summary>To determine maximum tolerate dose safety profile S-3304 patient biopsy accessible cancer fail previous therapy standard therapy available . To determine pharmacokinetic profile S-3304 patient population</brief_summary>
	<brief_title>A Phase 1 Study S-3304 Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>S 3304</mesh_term>
	<criteria>Inclusion criterion : Biopsy proven diagnosis solid tumor ( ) biopsy accessible lesion ( ) Must able tolerate oral medication Exclusion criterion Patients serious illness Patients receive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2003</verification_date>
	<keyword>neovascularization</keyword>
	<keyword>matrix metalloproteinases</keyword>
	<keyword>antiangiogenesis</keyword>
	<keyword>type IV collagenase</keyword>
</DOC>